Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?
作者信息
Sheridan D J, Kingsbury M P, Flores N A
机构信息
Academic Cardiology Unit, National Heart and Lung Institute, Imperial College of Science Technology and Medicine, St Mary's Hospital, London, UK.
出版信息
Br J Clin Pharmacol. 1999 Feb;47(2):125-30. doi: 10.1046/j.1365-2125.1999.00871.x.
Abstract
摘要
相似文献
1
Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?左心室肥厚的消退；合适的治疗目标是什么？
Br J Clin Pharmacol. 1999 Feb;47(2):125-30. doi: 10.1046/j.1365-2125.1999.00871.x.
2
Regression of left ventricular hypertrophy.左心室肥厚的消退
JAMA. 1996 Aug 21;276(7):526-7. doi: 10.1001/jama.1996.03540070022017.
3
Regression of left ventricular hypertrophy. How and why?左心室肥厚的消退。方式及原因？
JAMA. 1996 May 15;275(19):1517-8.
4
Prognostic significance of left ventricular hypertrophy regression.左心室肥厚逆转的预后意义
Adv Exp Med Biol. 1997;432:199-205. doi: 10.1007/978-1-4615-5385-4_22.
5
Effect of antihypertensive therapy on left ventricular hypertrophy and on its pathophysiologic sequelae.
Blood Press Suppl. 1992;1:35-6; discussion 37.
6
7
Left ventricular hypertrophy: unresolved issues.左心室肥厚：未解决的问题。
Curr Hypertens Rep. 1999 Aug;1(4):331-2. doi: 10.1007/s11906-999-0041-6.
8
Hypertension and left ventricular hypertrophy: what is the link?高血压与左心室肥厚：二者有何关联？
R I Med. 1993 May;76(5):245-8.
9
Left ventricular hypertrophy regression: the LIVE trial.左心室肥厚逆转：LIVE试验
Cardiologia. 1999 Dec;44 Suppl 1(Pt 2):541-3.
10
Single-drug therapy and reduction of left ventricular mass in hypertension.高血压的单药治疗与左心室质量降低
Cardiologia. 1998 Nov;43(11):1177-83.
引用本文的文献
1
The functional consequences of sodium channel Na 1.8 in human left ventricular hypertrophy.钠离子通道 Na1.8 在人类左心室肥厚中的功能后果。
ESC Heart Fail. 2019 Feb;6(1):154-163. doi: 10.1002/ehf2.12378. Epub 2018 Oct 30.
2
Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities.生育三烯酚是一种针对与衰老相关的心血管疾病及其相关并发症的心脏保护剂。
Nutr Metab (Lond). 2018 Jan 19;15:6. doi: 10.1186/s12986-018-0244-4. eCollection 2018.
3
Is hepatic steatosis associated with left ventricular mass index increase in the general population?在普通人群中，肝脂肪变性与左心室质量指数增加有关吗？
World J Hepatol. 2017 Jul 8;9(19):857-866. doi: 10.4254/wjh.v9.i19.857.
4
Factors Contributing to Development and Reversal of LVH: A Pilot Study.导致左心室肥厚发展与逆转的因素：一项初步研究。
J Clin Diagn Res. 2016 May;10(5):OC17-20. doi: 10.7860/JCDR/2016/19747.7767. Epub 2016 May 1.
5
Evidence for distinct effects of exercise in different cardiac hypertrophic disorders.运动在不同心脏肥厚性疾病中具有不同作用的证据。
Life Sci. 2015 Feb 15;123:100-6. doi: 10.1016/j.lfs.2015.01.007. Epub 2015 Jan 26.
6
Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.p21激活激酶1生物活性肽对血管紧张素II诱导的心脏肥大及相关室性心律失常的抑制作用
PLoS One. 2014 Jul 11;9(7):e101974. doi: 10.1371/journal.pone.0101974. eCollection 2014.
本文引用的文献
1
Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension.高血压左心室肥厚消退多中心研究中的集中式超声心动图质量控制
J Hypertens. 1998 Apr;16(4):531-5. doi: 10.1097/00004872-199816040-00015.
2
Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension.依那普利和维拉帕米对系统性高血压患者心肌血流的比较作用
Circulation. 1997 Aug 5;96(3):864-73. doi: 10.1161/01.cir.96.3.864.
3
Changes in cell-to-cell electrical coupling associated with left ventricular hypertrophy.与左心室肥厚相关的细胞间电偶联变化。
Circ Res. 1997 Jun;80(6):765-71. doi: 10.1161/01.res.80.6.765.
4
Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.单药治疗对轻至中度高血压患者左心室质量降低的影响：六种抗高血压药物的比较。退伍军人事务部抗高血压药物合作研究组。
Circulation. 1997 Apr 15;95(8):2007-14. doi: 10.1161/01.cir.95.8.2007.
5
Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy?抗高血压药物在使左心室肥厚消退的能力上是否存在差异？
Circulation. 1997 Apr 15;95(8):1983-5. doi: 10.1161/01.cir.95.8.1983.
6
Regression of left ventricular dilatation and hypertrophy after aortic valve replacement.主动脉瓣置换术后左心室扩张及肥厚的消退
Int J Cardiol. 1996 Dec 13;57(3):217-25. doi: 10.1016/s0167-5273(96)02803-3.
7
Intracellular pH and H+ buffering capacity in guinea-pigs with left ventricular hypertrophy induced by constriction of the thoracic aorta.
Exp Physiol. 1997 Jan;82(1):227-30. doi: 10.1113/expphysiol.1997.sp004011.
8
Left ventricular hypertrophy and QT dispersion in hypertension.高血压患者的左心室肥厚与QT离散度
Hypertension. 1996 Nov;28(5):791-6. doi: 10.1161/01.hyp.28.5.791.
9
Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).依那普利与硝苯地平降低系统性高血压患者左心室肥厚的比较（PRESERVE试验）
Am J Cardiol. 1996 Jul 1;78(1):61-5. doi: 10.1016/s0002-9149(96)00228-7.
10
Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function.
Am J Cardiol. 1996 Jul 1;78(1):56-60. doi: 10.1016/s0002-9149(96)00227-5.
Zotero 插件